Irreversible Electroporation Margin Accentuation in Pancreaticoduodenectomy: A Propensity Score Matching Analysis

  • 0Department of Surgery, Methodist Health System, Dallas, TX, USA.

|

|

Summary

This summary is machine-generated.

Margin accentuation using irreversible electroporation (MA-IRE) improves overall survival in pancreatic cancer patients. This technique is safe and may activate immune cells, but does not affect recurrence or complications.

Area Of Science

  • Oncology
  • Surgical Oncology
  • Medical Technology

Background

  • Pancreatic cancer presents significant challenges in treatment and survival.
  • Margin accentuation using irreversible electroporation (MA-IRE) is a technique explored to improve outcomes.
  • Limited comparative data exists for MA-IRE versus standard care in pancreatic cancer patients.

Purpose Of The Study

  • To compare outcomes of pancreatic cancer patients treated with MA-IRE versus those who did not receive MA-IRE.
  • To evaluate the impact of MA-IRE on overall survival (OS), disease-free survival (DFS), margin status, and complications.
  • To assess the safety and potential mechanisms of MA-IRE in pancreaticoduodenectomy (PD).

Main Methods

  • Retrospective analysis of pancreatic adenocarcinoma patients undergoing PD (2017-2022).
  • Exclusion of patients who received neoadjuvant chemotherapy for major vessel involvement.
  • One-to-one propensity score matching (PSM) to create comparable MA-IRE and non-MA-IRE groups.

Main Results

  • Seventeen MA-IRE patients were matched with 19 non-MA-IRE controls.
  • MA-IRE group demonstrated significantly improved OS (746 vs. 509 days, p=0.034).
  • No significant differences were observed in DFS, margin status, or 30-day complication rates between groups post-matching.

Conclusions

  • MA-IRE in PD is associated with longer OS in pancreatic cancer patients.
  • MA-IRE does not appear to impact margin status, DFS, or postoperative complications.
  • Findings suggest MA-IRE may promote immune activation rather than direct margin control.